MedTrace Logo

Kabat Rehabilitation Versus Kinesiology Taping in Bell's Palsy

NCT07436624 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 38

Last updated 2026-02-27

No results posted yet for this study

Summary

This randomized controlled trial aims to compare the effects of Kabat rehabilitation versus kinesiology taping, both combined with conventional therapy, on facial asymmetry and functional disability in patients with unilateral Bell's palsy. A total of 38 participants will be recruited from the University of Lahore Teaching Hospital. Participants will be randomly assigned into two groups using a lottery method. Outcomes will be assessed using the Sunnybrook Facial Grading System and the Facial Disability Index at baseline, 4 weeks, and 8 weeks.

Conditions

  • Bell's Palsy
  • Facial Paralysis

Interventions

OTHER

Conventional Facial Therapy

Conventional therapy will consist of facial massage and electrical muscle stimulation (EMS). Massage techniques will include light stroking, tapping, and kneading of affected facial muscles for approximately 5 minutes. Electrical muscle stimulation will be delivered using interrupted galvanic current with a pulse width of 150 μs, frequency of 1-10 Hz, and intensity of 2-5 mA for 15 minutes. Small surface electrodes will be placed on key facial muscles including frontalis, zygomaticus major, orbicularis oris, and mentalis. Total duration of conventional therapy will be approximately 20 minutes per session.

OTHER

Kabat Rehabilitation

Kabat rehabilitation will be administered using proprioceptive neuromuscular facilitation (PNF) techniques. Manual resistance will be applied to stimulate contraction of affected facial muscles through three fulcrum points (upper, intermediate, and lower). Each muscle group (frontalis, corrugator supercilii, orbicularis oculi, procerus, orbicularis oris, and mentalis) will perform 10 repetitions for 2 sets. The Kabat component will last approximately 20 minutes per session. Treatment will be provided 5 sessions per week for 8 weeks.

Sponsors & Collaborators

  • University of Lahore

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-12-11
Primary Completion
2026-03-13
Completion
2026-04-12

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07436624 on ClinicalTrials.gov